Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI : Part 2—Ex vivo imaging: Added value and acquisition is a research paper published in Magnetic Resonance in Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 202788/Z/16/A
Wellcome Trust
Grant: 203139/A/16/Z
Wellcome Trust
Grant: 203139/Z/16/Z
National Institutes of Health
Grant: K01EB032898
National Institutes of Health
Grant: R01AG057991
National Institutes of Health
Grant: R01CA160620
National Institutes of Health
Grant: R01EB017230
National Institutes of Health
Grant: R01EB019980
National Institutes of Health
Grant: R01EB031765
National Institutes of Health
Grant: R01EB031954
National Institutes of Health
Grant: R01NS109090
National Institutes of Health
Grant: R01NS125020
National Institutes of Health
Grant: R56EB031765
FWCI
6.32
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords